These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25223448)

  • 1. Coronary artery disease: Stable CAD does not SIGNIFY ivabradine therapy.
    Lim GB
    Nat Rev Cardiol; 2014 Nov; 11(11):621. PubMed ID: 25223448
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P
    Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine, coronary heart disease, and heart failure: time for reappraisal.
    Stulc T; Ceška R
    Curr Atheroscler Rep; 2014 Dec; 16(12):463. PubMed ID: 25301354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the SIGNIFY trial.
    Grassi G
    Expert Opin Pharmacother; 2015; 16(12):1861-4. PubMed ID: 26153241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine in stable coronary artery disease.
    Stulc T; Ceska R
    N Engl J Med; 2014 Dec; 371(25):2435. PubMed ID: 25517717
    [No Abstract]   [Full Text] [Related]  

  • 7. Ivabradine in stable coronary artery disease.
    Fox K; Ford I; Ferrari R
    N Engl J Med; 2014 Dec; 371(25):2435. PubMed ID: 25517716
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy.
    Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):4-9. PubMed ID: 25544120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
    Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
    Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmic effects of ivabradine in patients with coronary artery disease.
    Murat SN; Orcan S; Akdemir R; Dogan M; Kara E; Balci M
    Clin Invest Med; 2009 Oct; 32(5):E322-6. PubMed ID: 19796572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
    Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
    Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
    Tandon R; Agakishiev D; Freese RL; Thompson J; Nijjar PS
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230402. PubMed ID: 38814188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart rate modulation in stable ischemic heart disease: what we have learned from the SIGNIFY study?].
    Perna GP; Battistoni I; Angelini L
    G Ital Cardiol (Rome); 2015 Mar; 16(3):155-60. PubMed ID: 25837459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
    Tagliamonte E; Cirillo T; Rigo F; Astarita C; Coppola A; Romano C; Capuano N
    Adv Ther; 2015 Aug; 32(8):757-67. PubMed ID: 26293212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.